Factors influencing automation decisions in cell & advanced therapy manufacture

15 NOVEMBER 2016

Bioinsights Article

Brian Hanrahan, Invetech Program Manager, Cell Therapy, was recently interviewed by BioInsights as part of their November Spotlight on Automation and single-use systems in cell & gene therapy manufacture: Realizing the potential.

In this article, Brian discusses the main drivers for moving towards automated manufacturing processes, when companies should start to develop an automation plan, how to prioritize which processes to automate, and the role automation plays in ensuring reproducibility and achieving a reduction in the costs of goods.

Read the full article here.